1. BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
- Author
-
Pancrazzi Pancrazzi, Bloise Bloise, Moncada Moncada, Perticucci Perticucci, Vecchietti Vecchietti, Pompili Pompili, Ricciarini Ricciarini, Lenzi Lenzi, Gatteschi Gatteschi, Giusti Giusti, Rosito Rosito, Del Buono Del Buono, Belardi Belardi, Bruni Bruni, Borri Borri, Campione Campione, Laurini Laurini, Occhini Occhini, Presenti Presenti, Viticchi Viticchi, Rossi Rossi, Bardi Bardi, D'Urso D'Urso, Dei Dei, Venezia Venezia, Scala Scala, Bengala Bengala, Decarli Decarli, Carnevali Carnevali, Milandri Milandri, and Ognibene Ognibene
- Subjects
liquid biopsy ,cfDNA ,NGS ,Genetics ,QH426-470 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background Liquid biopsy is mainly used to identify tumor cells in pulmonary neoplasms. It is more often used in research than in clinical practice. The BL-MOL-AR study aims to investigate the efficacy of next-generation sequencing (NGS) and clinical interpretation of the circulating free DNA (cfDNA) levels. This study reports the preliminary results from the first samples analyzed from patients affected by various neoplasms: lung, intestinal, mammary, gastric, biliary, and cutaneous.
- Published
- 2023
- Full Text
- View/download PDF
